Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate Extension in Postmenopausal Osteoporosis
NCT00577421Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of risedronate in postmenopausal osteoporosis, sponsored by Warner Chilcott. Started Jun 2003; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00577421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577421.